Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: AIDS. 2021 Jul 15;35(9):1395–1402. doi: 10.1097/QAD.0000000000002897

Table 3:

Partial* Correlations Between AT Density and Biomarker Concentrations.

VAT HU P value SAT HU P value

Baseline*
Adiponectin (μg/mL) 0.11 0.14 −0.21 0.007
CRP (mg/L) −0.10 0.22 0.03 0.72
PAI-1 Activity (IU/mL) −0.02 0.81 0.10 0.23
TPA Activity (IU/mL) 0.17 0.03 −0.10 0.20
HOMA-IR 0.12 0.02 0.21 <0.001
IGF-1 (ng/mL) −0.05 0.31 −0.04 0.41
Change in VAT HU P value Change in SAT HU P value
26-week change**
Adiponectin (μg/mL) 0.19 0.02 0.18 0.02
CRP (mg/L) 0.04 0.57 0.11 0.15
PAI-1 Activity (IU/mL) −0.05 0.50 −0.02 0.83
TPA Activity (IU/mL) 0.06 0.42 0.03 0.69
HOMA-IR −0.02 0.73 0.02 0.69
IGF-1 (ng/mL) 0.09 0.08 0.14 0.01
*

Adjusted for baseline AT area

**

Adjusted for change in AT area

CRP=C-reactive protein, PAI-1=plasminogen activator inhibitor, IU=international units, TPA=tissue plasminogen activator, HOMA-IR=homeostatic assessment model assessment of insulin resistance, IGF-1=insulin-like growth factor-1, VAT=visceral adipose tissue, SAT=subcutaneous adipose tissue, HU=Hounsfield Units